Please ensure Javascript is enabled for purposes of website accessibility

Why Tandem Diabetes Care Stock Jumped Today

By Keith Speights – Sep 7, 2021 at 4:20PM

Key Points

  • ETFs and mutual funds that track the index will now have to add Tandem Diabetes Care to their holdings.

Motley Fool Issues Rare “All In” Buy Alert

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The stock is being added to the S&P MidCap 400 Index.

What happened

Shares of Tandem Diabetes Care (TNDM 4.15%) were jumping 12.9% higher as of 3:51 p.m. EDT on Tuesday. The gain came after S&P Global announced that the stock would be added to the S&P MidCap 400 Index effective Sept. 20.

So what

There's one big advantage that mid-cap stocks obtain from being added to the S&P MidCap 400 Index. Any mutual fund or exchange-traded fund that tracks the index must add the stocks to their holdings.

Stock symbols and prices on a digital screen.

Image source: Getty Images.

That's the main reason Tandem enjoyed a boost today. Investors liked the extra attention that the company will now receive from funds. However, any positive momentum for the stock from its addition to the MidCap 400 should only be temporary. Once funds have bought shares of Tandem, the catalyst will be over.

Now what

What really matters for Tandem is the sale of its insulin pumps. The good news for investors is that the company generated record sales in the second quarter thanks to rapid growth in the U.S. market. Even better, it is only in its early stages of penetrating the international market.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends S&P Global. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tandem Diabetes Care Stock Quote
Tandem Diabetes Care
TNDM
$41.18 (4.15%) $1.64
S&P Global Stock Quote
S&P Global
SPGI
$351.01 (-1.93%) $-6.90

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
356%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.